Domov › Kolorektalni rak › Maryland › Baltimore
Klinične študije za Kolorektalni rak v Baltimore, MD
31 študij za Kolorektalni rak išče udeležence na lokacijah v Baltimore in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Family Communications After Genetic Testing
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- in še 2
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #14, Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Greater Baltimore Medical Center, Baltimore
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Vključevanje udeležencevFaza 3
- MedStar Franklin Square Medical Center, Baltimore
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Vključevanje udeležencevFaza 3
- MedStar Franklin Square Medical Center, Baltimore
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 2/3
- Local Institution - 0262, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Vključevanje udeležencevFaza 1
- United Theranostics, Glen Burnie · 9 mi stran
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Vključevanje udeležencevFaza 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Johns Hopkins, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Vključevanje udeležencevFaza 3
- Saint Agnes Hospital, Baltimore
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- United Theranostics, Glen Burnie · 9 mi stran
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Vključevanje udeležencevFaza 1/2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Clinical Study Site, Baltimore
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Vključevanje udeležencevFaza 2
- Research Site, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Vključevanje udeležencevFaza 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Vključevanje udeležencevFaza 1
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Vključevanje udeležencevFaza 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Vključevanje udeležencevFaza 2
- Johns Hopkins Hospital /ID# 275645, Baltimore
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Vključevanje udeležencevFaza 4
- Mercy Medical Center, Baltimore
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Vključevanje udeležencev
- Johns Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Vključevanje udeležencevFaza 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi stran
- United Theranostics - Chesapeake, Glen Burnie · 9 mi stran
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Johns Hopkins Hospital, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Vključevanje udeležencevFaza 1/2
- Johns Hopkins University, Baltimore
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Vključevanje udeležencevFaza 2
- Johns Hopkins SKCCC, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Vključevanje udeležencevFaza 1/2
- Johns Hopkins University, Baltimore
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Vključevanje udeležencevFaza 2
- NGM Clinical Study Site, Baltimore
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi stran
- in še 1
Študije za Kolorektalni rak v drugih mestih
- Houston, TX102 študij
- New York City, NY78 študij
- Nashville, TN69 študij
- Boston, MA63 študij
- Los Angeles, CA59 študij
- Arlington, VA52 študij
- St. Louis, MO50 študij
- San Antonio, TX46 študij
- Philadelphia, PA44 študij
- Grand Rapids, MI40 študij
- Baldwin Park, CA37 študij
- Chicago, IL34 študij
Druge študije v Baltimore
- Nemalicelični pljučni rak60 študij
- Rak dojke47 študij
- Rak prostate43 študij
- Rak pljuč40 študij
- Rak (vse vrste)37 študij
- Rak trebušne slinavke31 študij
- Metastatski rak28 študij
- Debelost26 študij
- Rak mehurja24 študij
- Srčno popuščanje24 študij
- Rak jajčnikov22 študij
- Možganska kap21 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.